Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bone graft putty may strengthen immediate dental implants

NCT ID NCT07709676

Completed Disease control Sponsor: Minia University Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This trial tests whether placing a synthetic bone graft material called beta-tricalcium phosphate into the gap around a dental implant helps it stay stable and promotes bone growth. The study involves 16 adults aged 20 to 50 who need an upper front tooth replaced immediately after extraction and have a gap larger than 2 mm. Half receive the graft, half do not, and implant stability and bone density are measured over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
beta-tricalcium phosphate bone graft putty placed into the gap around a dental implant
What this could lead to
If successful, this approach could improve the success and durability of immediate dental implants in patients with large gaps between the implant and the tooth socket.
What could go wrong
This is a small, early-stage trial with only 16 patients, so results may not apply to everyone. The bone graft material may not integrate well or could cause complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALVEOLAR BONE LOSS* / THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alveolar Bone Loss periodontitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALVEOLAR BONE LOSS* / THERAPY TOOTH LOSS IN THE ANTERIOR MAXILLA

Contacts and locations

Locations

  • Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Suez Canal University

    Ismailia, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.